EPHA2 and breast carcinoma: Dimeric 123B9 peptide, targeting EphA2 (related to cancer metastasis, overexpressed in melanomas, ovarian, prostate, lung, and breast cancers), conjugated with paclitaxel inhibits lung metastasis in breast cancer models [186].